🔎 Trials Near Me

Home › Social Anxiety Disorder › NCT05858346

Comparing TBT to Disorder-Specific Psychotherapy in Veterans With Social Anxiety Disorder

Recruiting

A Randomized Clinical Trial Comparing Transdiagnostic Behavior Therapy to Disorder-Specific Psychotherapy in the Recovery of Veterans With Social Anxiety Disorder and Comorbid PTSD Symptomatology

Who can join

Ages 18 to 80 · All sexes

Full eligibility criteria
Inclusion Criteria:

* Participants must be Veterans and registered at Ralph H. Johnson Veterans Affairs Health Care System
* Participants must be clearly competent to provide informed consent for research participation
* Participants must meet DSM-5 criteria for social anxiety disorder
* Participants must have clinically significant symptoms of comorbid posttraumatic stress

Exclusion Criteria:

* recent history (\< 2 months) of psychiatric hospitalization or a suicide attempt as documented in their medical record,
* acute, severe illness or medical condition that likely will interfere with study procedures as documented in their medical record
* recent start of new psychiatric medication(s) (\< 4 weeks),
* primary diagnosis of a condition associated with psychotic symptoms, personality disorder, substance use disorder, or bipolar disorder.

About the study

Cognitive behavioral therapy (CBT) is a brief, efficient, and effective treatment for individuals with depressive/anxiety disorders. However, CBT is largely underutilized within the Department of Veterans Affairs due to the cost and burden of trainings necessary to deliver all of the related disorder-specific treatments (DSTs). Transdiagnostic Behavior Therapy (TBT), in contrast, is specifically designed to address numerous distinct disorders within a single protocol in Veterans with depressive/anxiety disorders. The proposed research seeks to evaluate the efficacy of TBT by assessing psychiatric symptomatology and related impairment outcomes in Veterans with social anxiety disorder and comorbid posttraumatic stress via a randomized controlled trial of TBT and an existing DST. Assessments will be completed at pre-, mid-, and post-treatment, and at 6-month follow-up. Process variables also will be investigated.

What is being tested

Sponsor: VA Office of Research and Development · Participants: 264 · Started: Apr 1, 2024

Contact the study team

Official record on ClinicalTrials.gov — NCT05858346

Locations in the U.S.

South CarolinaRalph H. Johnson VA Medical Center, Charleston, SC, Charleston

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.